Bio-Techne Corporation

NASDAQ
TECH
Stock
Yield per half year: -16.19%
Dividend yield: 0.4884%
Sector: Healthcare

Company Analysis Bio-Techne Corporation

Download the report: word Word pdf PDF

1. Summary

Disadvantages

  • Price (51.53 $) is higher than fair price (8.57 $)
  • Dividends (0.4884%) are below the sector average (0.527%).
  • The stock's return over the last year (-32.29%) is lower than the sector average (-1.85%).
  • Current debt level 15.52% has increased over 5 years from 0.6633%.
  • The company's current efficiency (ROE=8.33%) is lower than the sector average (ROE=14.17%)

Similar companies

Alexion

ABIOMED

Gilead Sciences

Amgen

2. Share price and performance

2.1. Share price

2.3. Market efficiency

Bio-Techne Corporation Healthcare Index
7 days 2.3% 9.1% 1.2%
90 days 8.3% 4.9% 21.7%
1 year -32.3% -1.8% 21.8%

TECH vs Sector: Bio-Techne Corporation has significantly underperformed the "Healthcare" sector by -30.44% over the past year.

TECH vs Market: Bio-Techne Corporation has significantly underperformed the market by -54.06% over the past year.

Stable price: TECH is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: TECH with weekly volatility of -0.621% over the past year.

3. Summary of the report

3.1. General

P/E: 71.24
P/S: 10.33

3.2. Revenue

EPS 1.05
ROE 8.33%
ROA 6.29%
ROIC 14.42%
Ebitda margin 26.78%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (51.53 $) is higher than the fair price (8.57 $).

Price is higher than fair: The current price (51.53 $) is 83.4% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (71.24) is higher than that of the sector as a whole (64.15).

P/E vs Market: The company's P/E (71.24) is lower than that of the market as a whole (90.03).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (5.79) is lower than that of the sector as a whole (18.96).

P/BV vs Market: The company's P/BV (5.79) is lower than that of the market as a whole (9.39).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (10.33) is lower than that of the sector as a whole (32.77).

P/S vs Market: The company's P/S indicator (10.33) is higher than that of the market as a whole (10.12).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (39.45) is lower than that of the sector as a whole (274.79).

EV/Ebitda vs Market: The company's EV/Ebitda (39.45) is lower than that of the market as a whole (50.91).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -5.32% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-5.32%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-15.75%).

5.4. ROE

ROE vs Sector: The company's ROE (8.33%) is lower than that of the sector as a whole (14.17%).

ROE vs Market: The company's ROE (8.33%) is lower than that of the market as a whole (11.64%).

5.5. ROA

ROA vs Sector: The company's ROA (6.29%) is higher than that of the sector as a whole (1.18%).

ROA vs Market: The company's ROA (6.29%) is lower than that of the market as a whole (6.89%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (14.42%) is higher than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (14.42%) is higher than that of the market as a whole (11.08%).

6. Finance

6.1. Assets and debt

Debt level: (15.52%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0.6633% to 15.52%.

Excess of debt: The debt is not covered by net income, percentage 249.57%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0.4884% is below the average for the sector '0.527%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 0.4884% has been steadily paid over the past 7 years, DSI=0.86.

Weak dividend growth: The company's dividend yield 0.4884% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (29.99%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Selling More insider purchases by 112.27% over the last 3 months.

8.2. Latest transactions

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Bio-Techne Corporation

9.3. Comments